131 related articles for article (PubMed ID: 19710506)
1. Nf1 deficiency cooperates with oncogenic K-RAS to induce acute myeloid leukemia in mice.
Cutts BA; Sjogren AK; Andersson KM; Wahlstrom AM; Karlsson C; Swolin B; Bergo MO
Blood; 2009 Oct; 114(17):3629-32. PubMed ID: 19710506
[TBL] [Abstract][Full Text] [Related]
2. The GAP-related domain of neurofibromin attenuates proliferation and downregulates N- and K-Ras activation in Nf1-negative AML cells.
Morgan KJ; Rowley MA; Wiesner SM; Hasz DE; Van Ness B; Largaespada DA
Leuk Res; 2007 Aug; 31(8):1107-13. PubMed ID: 17222906
[TBL] [Abstract][Full Text] [Related]
3. Loss of the nf1 tumor suppressor gene decreases fas antigen expression in myeloid cells.
Hiatt K; Ingram DA; Huddleston H; Spandau DF; Kapur R; Clapp DW
Am J Pathol; 2004 Apr; 164(4):1471-9. PubMed ID: 15039234
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras.
Kalra R; Paderanga DC; Olson K; Shannon KM
Blood; 1994 Nov; 84(10):3435-9. PubMed ID: 7949098
[TBL] [Abstract][Full Text] [Related]
5. Tie2-Cre-induced inactivation of a conditional mutant Nf1 allele in mouse results in a myeloproliferative disorder that models juvenile myelomonocytic leukemia.
Gitler AD; Kong Y; Choi JK; Zhu Y; Pear WS; Epstein JA
Pediatr Res; 2004 Apr; 55(4):581-4. PubMed ID: 14739366
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo effects of a farnesyltransferase inhibitor on Nf1-deficient hematopoietic cells.
Mahgoub N; Taylor BR; Gratiot M; Kohl NE; Gibbs JB; Jacks T; Shannon KM
Blood; 1999 Oct; 94(7):2469-76. PubMed ID: 10498620
[TBL] [Abstract][Full Text] [Related]
7. Leukemic potential of doubly mutant Nf1 and Wv hematopoietic cells.
Ingram DA; Wenning MJ; Shannon K; Clapp DW
Blood; 2003 Mar; 101(5):1984-6. PubMed ID: 12393498
[TBL] [Abstract][Full Text] [Related]
8. Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency.
Sachs Z; Been RA; DeCoursin KJ; Nguyen HT; Mohd Hassan NA; Noble-Orcutt KE; Eckfeldt CE; Pomeroy EJ; Diaz-Flores E; Geurts JL; Diers MD; Hasz DE; Morgan KJ; MacMillan ML; Shannon KM; Largaespada DA; Wiesner SM
Haematologica; 2016 Oct; 101(10):1190-1199. PubMed ID: 27418650
[TBL] [Abstract][Full Text] [Related]
9. NF1 inactivation in adult acute myelogenous leukemia.
Parkin B; Ouillette P; Wang Y; Liu Y; Wright W; Roulston D; Purkayastha A; Dressel A; Karp J; Bockenstedt P; Al-Zoubi A; Talpaz M; Kujawski L; Liu Y; Shedden K; Shakhan S; Li C; Erba H; Malek SN
Clin Cancer Res; 2010 Aug; 16(16):4135-47. PubMed ID: 20505189
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of bone marrow levels of neurofibromatosis-1 protein and ras oncogene mutations in patients with acute myeloid leukemia and myelodysplastic syndrome.
Lu D; Nounou R; Beran M; Estey E; Manshouri T; Kantarjian H; Keating MJ; Albitar M
Cancer; 2003 Jan; 97(2):441-9. PubMed ID: 12518368
[TBL] [Abstract][Full Text] [Related]
11. Nf1 haploinsufficiency and Icsbp deficiency synergize in the development of leukemias.
Koenigsmann J; Rudolph C; Sander S; Kershaw O; Gruber AD; Bullinger L; Schlegelberger B; Carstanjen D
Blood; 2009 May; 113(19):4690-701. PubMed ID: 19228926
[TBL] [Abstract][Full Text] [Related]
12. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY
Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106
[TBL] [Abstract][Full Text] [Related]
13. Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells.
McDaniel AS; Allen JD; Park SJ; Jaffer ZM; Michels EG; Burgin SJ; Chen S; Bessler WK; Hofmann C; Ingram DA; Chernoff J; Clapp DW
Blood; 2008 Dec; 112(12):4646-54. PubMed ID: 18768391
[TBL] [Abstract][Full Text] [Related]
14. Increased neurofibromatosis 1 gene expression in astrocytic tumors: positive regulation by p21-ras.
Gutmann DH; Giordano MJ; Mahadeo DK; Lau N; Silbergeld D; Guha A
Oncogene; 1996 May; 12(10):2121-7. PubMed ID: 8668337
[TBL] [Abstract][Full Text] [Related]
15. Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis.
Balgobind BV; Van Vlierberghe P; van den Ouweland AM; Beverloo HB; Terlouw-Kromosoeto JN; van Wering ER; Reinhardt D; Horstmann M; Kaspers GJ; Pieters R; Zwaan CM; Van den Heuvel-Eibrink MM; Meijerink JP
Blood; 2008 Apr; 111(8):4322-8. PubMed ID: 18172006
[TBL] [Abstract][Full Text] [Related]
16. Loss of Dnmt3a and endogenous Kras(G12D/+) cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis.
Chang YI; You X; Kong G; Ranheim EA; Wang J; Du J; Liu Y; Zhou Y; Ryu MJ; Zhang J
Leukemia; 2015 Sep; 29(9):1847-56. PubMed ID: 25801914
[TBL] [Abstract][Full Text] [Related]
17. The interferon consensus sequence-binding protein activates transcription of the gene encoding neurofibromin 1.
Zhu C; Saberwal G; Lu Y; Platanias LC; Eklund EA
J Biol Chem; 2004 Dec; 279(49):50874-85. PubMed ID: 15371411
[TBL] [Abstract][Full Text] [Related]
18. Nf1 and Gmcsf interact in myeloid leukemogenesis.
Birnbaum RA; O'Marcaigh A; Wardak Z; Zhang YY; Dranoff G; Jacks T; Clapp DW; Shannon KM
Mol Cell; 2000 Jan; 5(1):189-95. PubMed ID: 10678181
[TBL] [Abstract][Full Text] [Related]
19. Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes.
Dasgupta B; Li W; Perry A; Gutmann DH
Cancer Res; 2005 Jan; 65(1):236-45. PubMed ID: 15665300
[TBL] [Abstract][Full Text] [Related]
20. Role of TC21/R-Ras2 in enhanced migration of neurofibromin-deficient Schwann cells.
Huang Y; Rangwala F; Fulkerson PC; Ling B; Reed E; Cox AD; Kamholz J; Ratner N
Oncogene; 2004 Jan; 23(2):368-78. PubMed ID: 14724565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
